Terumo Corporation (TRUMY)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Shinjiro Sato | Corporate Advisor & Director | 792.12k | -- | 1960 |
| Mr. Hikaru Samejima | President, CEO & Director | -- | -- | 1964 |
| Jin Hagimoto | CFO, CIO, GM of CFO Office, Controller & Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS | -- | -- | -- |
| Shinji Omori | CTO, GM of DX Promotion Dept. R&D Division and Executive Officer | -- | -- | -- |
| Ms. Miho Mizuguchi | Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department | -- | -- | -- |
| Tomoko Adachi | Chief Human Resources Officer & Group Executive Officer | -- | -- | -- |
| Mr. Shoji Hatano | Director & Corporate Advisor | -- | -- | 1959 |
| James Rushworth | Group Executive Officer & Chief Commercial Officer | -- | -- | -- |
| Mr. Kazunori Hirose | Director & Group Managing Executive Officer | -- | -- | 1964 |
| Itaru Sakaguchi | Group Managing Executive Officer | -- | -- | -- |
Terumo Corporation
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 30,207
Description
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
Corporate Governance
Recent Events
- Sep 28, 2023Ex-Dividend Date
- Dec 19, 2019Dividend Date
Upcoming Events
Upcoming Events Information Not Available